Kapağı yeniden konumlandırmak için sürükleyin
Gruplar
Henüz hiçbir gruba katılmadı
Yaklaşık
In response to the rise in obesity and diabetes, Dubai’s health authorities are placing an emphasis on preventive care. Mounjaro, while still primarily used as a treatment, aligns with these preventative objectives by helping reduce the risks associated with chronic health conditions before they become severe. As a result, there is potential for Dubai’s healthcare policy to integrate Mounjaro more extensively into treatment protocols for Type 2 diabetes, enabling physicians to recommend it more widely. Moreover, insurance companies are increasingly encouraged to cover novel medications like Mounjaro, which has prompted several large insurers in the UAE to consider expanding coverage options for diabetes treatments.
Avatarını kırp
